Las Vegas, NV -- (SBWIRE) -- 01/15/2014 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: GT Advanced Technologies Inc(NASDAQ:GTAT), ARMOUR Residential REIT, Inc.(NYSE:ARR), Capstone Turbine Corporation (NASDAQ:CPST), Orexigen Therapeutics, Inc.(NASDAQ:OREX)
GT Advanced Technologies Inc(NASDAQ:GTAT) was a volume gainer of 3.76 million shares and the average volume of the stock remained 5.50 million shares. The stock opened the session at $8.88 and finished at the end of the day at $9.14 and the stock escalated 4.58%.The market capitalization of the stock remained 1.21 billion. GT Advanced Technologies Inc. provides crystal growth equipment and solutions for the solar, light emitting diode (LED), and electronics industries worldwide. The company operates through three segments: Polysilicon; Photovoltaic (PV); and Sapphire.
For How Long GTAT will fight for Profitability? Read This Trend Analysis report
In the preceding trading session, ARMOUR Residential REIT, Inc.(NYSE:ARR) exchanged 3.76 million shares and the average volume remained 6.05 million shares. The stock closed the session at $4.04 with the drop of -0.74%. ARMOUR Residential REIT, Inc. is a real estate investment trust launched and managed by ARMOUR Residential Management LLC. It invests in the real estate markets of the United States. ARMOUR Residential REIT, Inc. was founded in 2008 and is based in Vero Beach, Florida.
Why Should Investors Buy ARR After the Recent Fall? Just Go Here and Find Out
Capstone Turbine Corporation (NASDAQ:CPST) enhanced 3.90% and its closing price was $1.60. The volume of the stock was 3.66 million shares and the average volume remained 3.89 million shares. The market capitalization of the stock remained 495.88 million. The beta of the stock remained 1.96. Capstone Turbine Corporation engages in developing, manufacturing, marketing, and servicing microturbine technology solutions for use in stationary distributed power generation applications worldwide.
Why Should Investors Buy CPST After The Recent Gain? Just Go Here and Find Out
Orexigen Therapeutics, Inc.(NASDAQ:OREX) exchanged 3.60 million shares in the previous trading session, and its average trading remained 2.88 million shares. OREX advanced 7.39% and it closed the trading at $6.54. The market capitalization of the stock remained 662.99 million. Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. Orexigen Therapeutics, Inc. was founded in 2002 and is headquartered in La Jolla, California.
For How Long OREX’s Gloss will Attract Investors? Find out via this report
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)